The Market's Edge: Unpacking Today's Top 'Final Trades'
Share- Nishadil
- September 24, 2025
- 0 Comments
- 3 minutes read
- 8 Views

As the trading day concludes and investors look ahead, the 'Final Trade' segment on CNBC always offers crucial insights into where top analysts see opportunity and risk. Today, the panel honed in on a diverse set of tickers: CERT, the gold miners ETF GDX, the small-cap barometer IWM, and energy giant MPC.
These picks represent a fascinating cross-section of the market, each with its own compelling narrative and potential implications for portfolios.
First up, CERT, a lesser-known but strategically significant player in the biotech space. Our analysts highlighted CERT's recent breakthroughs in gene therapy, suggesting that while speculative, the company is on the cusp of significant clinical milestones.
The bullish case hinges on upcoming trial data, which, if positive, could send shares soaring. Investors are advised to watch this name closely, understanding the inherent volatility but also the immense upside potential should their innovative treatments prove successful. It's a high-stakes bet, but one that could yield substantial rewards for those with a strong risk appetite.
Next, the focus shifted to the precious metals sector with the VanEck Gold Miners ETF (GDX).
Given the current global economic uncertainties and inflationary pressures, gold has re-emerged as a pivotal safe-haven asset. The discussion centered on GDX as a leveraged play on rising gold prices. Analysts noted that despite recent pullbacks, the underlying fundamentals for gold—driven by central bank policies and geopolitical tensions—remain strong.
GDX offers exposure to a basket of established gold mining companies, providing a degree of diversification within the sector. The sentiment here was cautiously optimistic, suggesting that GDX could provide a hedge against broader market volatility and benefit from sustained investor demand for tangible assets.
The conversation then turned to the bellwether for small-cap performance, the iShares Russell 2000 ETF (IWM).
Often seen as a barometer for domestic economic health, IWM's recent performance has been mixed. Our panel pointed to a crucial inflection point for small-cap stocks. While higher interest rates have historically pressured smaller companies, a potential easing of monetary policy or robust consumer spending could provide a significant tailwind.
The 'Final Trade' perspective on IWM was one of strategic patience. Analysts suggested that for long-term investors, any dips in IWM could present an attractive entry point, betting on the resilience and innovative capacity of American small businesses to drive future growth. It’s a testament to the belief that beneath the surface of large-cap dominance, the engines of localized economic activity are poised for a comeback.
Finally, the energy sector made its appearance with Marathon Petroleum Corporation (MPC).
As a major refiner and fuel retailer, MPC's performance is intrinsically linked to global energy demand and refining margins. With crude oil prices experiencing recent fluctuations and demand outlooks remaining robust, particularly in the travel and industrial sectors, MPC was presented as a solid value play.
Analysts underscored MPC's strong balance sheet, efficient operations, and potential for shareholder returns through dividends and buybacks. The consensus was that despite the ongoing energy transition, conventional energy companies like MPC still have a vital role to play and offer compelling investment propositions in the current environment.
It represents a pragmatic approach to capitalizing on sustained global energy needs.
In summary, today's 'Final Trades' offered a compelling blend of high-growth potential with CERT, defensive plays with GDX, a contrarian long-term view on IWM, and value in the energy sector with MPC. Investors are encouraged to conduct their own due diligence, but these insights provide a powerful starting point for navigating the complexities of today's dynamic markets.
.Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on